Related Articles for PubMed (Select 15691382)

TPO/Mpl Studies in Agnogenic Myeloid Metaplasia.

Hemavathy KC, Suppiah K, Hashmi G, Novetsky AD, Wang JC.

Cell Commun Signal. 2005 Feb 3;3(1):4.

PMID: 15691382 [PubMed - as supplied by publisher]

Related Articles Free article in PMC

Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.

Wang JC, Chang TH, Goldberg A, Novetsky AD, Lichter S, Lipton J.

Exp Hematol. 2006 Dec;34(12):1617-23.

PMID: 17157157 [PubMed - indexed for MEDLINE]

Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia.

Wang JC, Chen C, Lou LH, Mora M.

Leukemia. 1997 Nov;11(11):1827-32.

PMID: 9369414 [PubMed - indexed for MEDLINE]

Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.

Elliot MA, Yoon SY, Kao P, Li CY, Tefferi A.

Eur J Haematol. 2002 Mar;68(3):175-9.

PMID: 12068799 [PubMed - indexed for MEDLINE]

Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.

Drexler HG, Quentmeier H.

Leukemia. 1996 Sep;10(9):1405-21. Review.

PMID: 8751457 [PubMed - indexed for MEDLINE]

Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow.

Wang JC, Hashmi G.

Leuk Res. 2003 Jan;27(1):13-7.

PMID: 12479847 [PubMed - indexed for MEDLINE]

Functional roles of thrombopoietin-c-mpl system in essential thrombocythemia.

Matsumura I, Horikawa Y, Kanakura Y.

Leuk Lymphoma. 1999 Jan;32(3-4):351-8. Review.

PMID: 10037033 [PubMed - indexed for MEDLINE]

Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.

Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG.

Leukemia. 1996 Feb;10(2):297-310.

PMID: 8637239 [PubMed - indexed for MEDLINE]

High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.

Cohen-Solal K, Vitrat N, Titeux M, Vainchenker W, Wendling F.

Blood. 1999 May 1;93(9):2859-66.

PMID: 10216080 [PubMed - indexed for MEDLINE]

10:

Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia.

Corazza F, Hermans C, D'Hondt S, Ferster A, Kentos A, Benoît Y, Sariban E.

Blood. 2006 Mar 15;107(6):2525-30. Epub 2005 Nov 29.

PMID: 16317100 [PubMed - indexed for MEDLINE]

11:

Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.

Drexler HG, Quentmeier H.

Hum Cell. 1996 Dec;9(4):309-16. Review.

PMID: 9183663 [PubMed - indexed for MEDLINE]

12:

Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.

Muraoka K, Ishii E, Tsuji K, Yamamoto S, Yamaguchi H, Hara T, Koga H, Nakahata T, Miyazaki S.

Br J Haematol. 1997 Feb;96(2):287-92.

PMID: 9029014 [PubMed - indexed for MEDLINE]

13:

Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapy.

Kaban K, Kantarjian H, Talpaz M, O'Brien S, Cortes J, Giles FJ, Pierce S, Albitar M.

Cancer. 2000 Feb 1;88(3):570-6.

PMID: 10649249 [PubMed - indexed for MEDLINE]

14:

Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.

Horikawa Y, Matsumura I, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, Matsuzawa Y, Kanakura Y.

Blood. 1997 Nov 15;90(10):4031-8.

PMID: 9354672 [PubMed - indexed for MEDLINE]

15:

The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.

Debili N, Wendling F, Katz A, Guichard J, Breton-Gorius J, Hunt P, Vainchenker W.

Blood. 1995 Oct 1;86(7):2516-25.

PMID: 7545460 [PubMed - indexed for MEDLINE]

16:

Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.

Carver-Moore K, Broxmeyer HE, Luoh SM, Cooper S, Peng J, Burstein SA, Moore MW, de Sauvage FJ.

Blood. 1996 Aug 1;88(3):803-8.

PMID: 8704234 [PubMed - indexed for MEDLINE]

17:

Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.

Majka M, Ratajczak J, Villaire G, Kubiczek K, Marquez LA, Janowska-Wieczorek A, Ratajczak MZ.

Exp Hematol. 2002 Jul;30(7):751-60.

PMID: 12135673 [PubMed - indexed for MEDLINE]

18:

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, Galinsky I, DeAngelo DJ, Clark JJ, Lee SJ, Golub TR, Wadleigh M, Gilliland DG, Levine RL.

PLoS Med. 2006 Jul;3(7):e270.

PMID: 16834459 [PubMed - indexed for MEDLINE]

Recent Activity